 MOUNTAIN VIEW, Calif., March 29, 2022 GLOBE NEWSWIRE -- IGM Biosciences, Inc. Nasdaq: IGMS, a clinical-stage biotechnology company focused on creating and developing engineered IgM antibodies, today announced that the Company will host a conference call and live audio webcast today, Tuesday, March 29, 2022, at 8:00 am ET to discuss the Companys global collaboration agreement with Sanofi, as recently announced. 